Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026

Rhea-AI Summary

Pulmonx (Nasdaq: LUNG) will release its second quarter 2026 financial results after market close on Wednesday, July 29, 2026. Company management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET, with live and archived webcast access via the Investors section of the Pulmonx website.

News Market Reaction – LUNG

+0.69%

5 alerts

+0.69% Session close to close

$62.51M Market Cap

0.1x Rel. Volume

In the Jul 16 session, LUNG gained 0.69%, reflecting a mild positive market reaction. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This Q2 earnings-date announcement sits against a backdrop of mixed historical reactions to similar ...

Analysis

This Q2 earnings-date announcement sits against a backdrop of mixed historical reactions to similar notices and an average move of 1.66%. With an effective S-3/A shelf and recent insider net selling, investors may watch upcoming results for any funding or governance signals.

Key Figures

Earnings release date: July 29, 2026 Conference call time: 1:30 p.m. PT / 4:30 p.m. ET

2 metrics

Earnings release date July 29, 2026 Second quarter 2026 financial results release after market close

Conference call time 1:30 p.m. PT / 4:30 p.m. ET Management call to discuss Q2 2026 results

Previous Earnings date Reports

2 past events · Latest: Apr 15 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 15	Earnings date notice	Neutral	-2.7%	Scheduled first quarter 2026 results and related earnings call details.
Feb 20	Earnings date notice	Neutral	+6.0%	Announced Q4 and full year 2025 results date and conference call timing.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

For prior earnings-date notices, LUNG has shown mixed but slightly positive next-day moves, with one negative and one positive reaction and an average move of about 1.66%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2026 after the close of trading on Wednesday, July 29, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET.

A live and archived webcast of the event will be available on the “Investors” section of the Pulmonx website at https://investors.pulmonx.com/.

About Pulmonx Corporation
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx’s Zephyr^® Endobronchial Valve, Chartis^® Pulmonary Assessment System and StratX^® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option for improving breathing, activity and quality of life in patients with severe emphysema. For more information on the Zephyr Valves and the company, please visit www.pulmonx.com.

Pulmonx®, Chartis®, StratX®, and Zephyr® are registered trademarks of Pulmonx Corporation.

Contact
Brian Johnston or Webb Campbell
Gilmartin Group
investors@pulmonx.com

FAQ

When will Pulmonx (Nasdaq: LUNG) report its Q2 2026 financial results?

Pulmonx will report its Q2 2026 financial results on Wednesday, July 29, 2026 after the close of trading. According to Pulmonx, investors can then join a management-hosted conference call and webcast to review the quarterly results and related commentary.

What time is the Pulmonx (LUNG) Q2 2026 earnings conference call on July 29, 2026?

The Pulmonx Q2 2026 conference call begins at 1:30 p.m. PT / 4:30 p.m. ET on July 29, 2026. According to Pulmonx, management will discuss the company’s second quarter 2026 financial results and provide prepared remarks followed by an opportunity for investor questions.

How can investors access the Pulmonx (LUNG) Q2 2026 earnings webcast?

Investors can access the Pulmonx Q2 2026 earnings webcast via the “Investors” section of the company’s website at https://investors.pulmonx.com/. According to Pulmonx, both a live webcast and an archived replay of the conference call will be made available online.

Will a replay of the Pulmonx (LUNG) Q2 2026 earnings call be available?

Yes, a replay of the Pulmonx Q2 2026 earnings call will be available as an archived webcast. According to Pulmonx, investors can access the archived event in the Investors section of the company’s website following the live conference call on July 29, 2026.

What will Pulmonx management discuss on the Q2 2026 LUNG earnings call?

Pulmonx management will discuss the company’s second quarter 2026 financial results during the call. According to Pulmonx, the conference is scheduled after results are released and allows management to review performance and provide additional details for analysts and shareholders.